معرفی
Dr. Reem Karmali serves as an Associate Professor in the Department of Medicine (Hematology and Oncology) at Northwestern University's Feinberg School of Medicine. She is affiliated with the Robert H. Lurie Comprehensive Cancer Center and provides clinical care at Northwestern Memorial Hospital and Shirley Ryan AbilityLab.
- MD: University of Western Ontario, Canada (2006)
- MS: Rush University (2012)
- Residency: Rush University Medical Center, Internal Medicine (2009)
- Fellowship: Rush University Medical Center, Hematology-Oncology (2012)
Her research focuses on lymphoma treatment, particularly CAR T-cell therapy applications and novel immunotherapeutic approaches. Dr. Karmali has published extensively on outcomes of cellular therapies for hematologic malignancies, with recent work examining rehabilitation after CAR T-cell therapy, treatment resistance patterns, and combination immunotherapy approaches.
Her 2025 publications demonstrate a strong emphasis on real-world clinical applications of CAR T-cell therapy across various lymphoma subtypes, with particular attention to patient outcomes and treatment efficacy. These studies span multiple institutions through collaborative research networks.
- Internal Medicine Teaching Award, Northwestern University (2024)
- Division Faculty Teaching Award, Northwestern University (2023, 2022)
- Northwestern University Teaching Pin (2019, 2018)
Dr. Karmali actively contributes to national guidelines as a member of the ASCO Hematologic Malignancies Guideline Advisory Group and the NCCN Histiocytosis Panel. She chairs the Lymphoma Research Foundation Chicago Rounds and serves on the Ultmann Chicago Lymphoma Symposium. Her clinical trial work focuses on advancing CAR T-cell therapies for relapsed/refractory lymphomas through multiple active studies at Northwestern.
